LOBG 0.5MG TABLET contains Lobeglitazone which belongs to the group of medicines called Antidiabetic agents. It is used to manage type 2 diabetes mellitus patients who are inadequately controlled by diet and exercise and for whom where other anti-diabetic is inappropriate. Diabetes mellitus is a chronic, metabolic disease characterized by elevated levels of blood glucose (or blood sugar), which leads over time to serious damage to the heart, blood vessels, eyes, kidneys, and nerves.

Lobeglitazone acts as an insulin sensitizer by binding and activating peroxisome proliferator-activated receptors (PPAR) gamma within fat cells. Also, by promoting the binding of insulin at fat cells, LOBG 0.5MG TABLET has been shown to reduce blood sugar levels, lower hemoglobin A1C (HbA1C) levels, and improve lipid and liver profiles.

LOBG 0.5MG TABLET is not recommended for patients with liver impairment. Dosage adjustment is not necessary for renal impairment patients. The common side effects of taking this medicine are edema and weight gain. Consult your doctor if any of the above side persists for a longer duration.